 |
|
 |
|
ADHD is a common neurobiological disorder with multiple genetic and environmental origins. |
BioBehavioral Diagnostics Company (BioBDx) develops diagnostic systems that aid clinicians in the objective assessment of behavioral and neurobiological disorders. The company's lead product, the Quotient™ ADHD System1, is the first FDA cleared2 test that provides healthcare professionals with an office based ability to rapidly and precisely measure the three core symptom areas of
ADHD (inattention, hyperactivity and impulsivity).
1. The Quotient™ ADHD System was formerly known as the MMAT/ADHD™ System.
2. The U.S Food and Drug Administration has cleared the Quotient™ ADHD System for marketing
through a 510(k), which clearance permits the product’s sale in the United States.
BioBDx Announces Availability of
Quotient™ ADHD System
View Press Release